ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 932

Fibroblasts Senescence Is Observed in Rheumatoid and Osteoarthritic Synovial Tissues and Triggers a Pro-Inflammatory Program Ex Vivo

Manuel J Del Rey1, Alvaro Valin2, Alicia Usategui3, Sandra Ergueta3, Vanessa Miranda3, Jesús Fernández-Felipe3, Juan D. Cañete4, Francisco J Blanco5, Gabriel Criado3 and Jose L. Pablos6,7, 1Grupo de Enfermedades Inflamatorias y Autoinmunes, Servicio de Reumatología,, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, 2Grupo de Enfermedades Inflamatorias y Autoimmunes, Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, 3Grupo de Enfermedades Inflamatorias y Autoinmunes, Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, 4Rheumatology Department Hospital Clinic and IDIBAPS, Barcelona, Spain, Barcelona, Spain, 5Rheumatology Division (INIBIC-CHUAC), Osteoarticular and Aging Research Lab, Proteomics Unit, La Coruna, Spain, 6Servicio de Reumatología, Rheumatology Department, Hospital 12 de Octubre, Spain, Madrid, Spain, 7Grupo de Enfermedades Inflamatorias y Autoinmunes, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Fibroblasts, osteoarthritis and rheumatoid arthritis (RA), Senescent Cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S107 ACR Abstract: RA–Etiology & Pathogenesis I (928–933)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Inflammation is an important component of most age-related disorders. Cellular changes associated to aging are tightly connected with pro-inflammatory mechanisms. The purpose of this study is to analyze cellular senescence in synovial fibroblasts and its potential influence in the pathogenesis of chronic arthritis, including rheumatoid arthritis (RA) and osteoarthritis (OA).

Methods: The expression of senescence associated markers p16INK4 (p16) and Nanog was analyzed by immunohistochemistry (IHC) and immunofluorescence (IF) in synovial tissues from RA (n=43), OA (n=18), and non-inflammatory synovial tissues (n=15). Senescent synovial fibroblasts (SF) were quantified in cultures by senescence-associated beta-galactosidase (SA-β-gal) staining. For a model of stress-induced senescence, SF were cultured for 14 days after a short course of oxidative stress with H2O2 (200 mM for 1h on day 5) or exposure to TNFα (100 ng/ml for 72h on day 2). At 14 days, senescence and further response to stimulation with TNFα 20 ng/ml for 24h were analyzed. RNA was extracted to quantify IL-6, IL-8, MMP-3, MCP-1, p16 and p21 mRNA expression by qRT-PCR and culture supernatants were analyzed for IL-6 and IL-8 production by ELISA. Quantitative data were statistically analyzed by Pearson or Spearman correlation coefficient or Mann-Whitney test where appropriate.

Results: Synovial tissue expression of both p16 and Nanog was detected by IHC and correlated positively with the age of the donors regardless of their origin (p16: p=0.008/r=0.307; Nanog: p=0.001/r=0.413). p16(+) cell density was significantly higher in OA tissues (p=0.01) and Nanog(+) was higher in both RA (p=0.0006) or OA (p<0.0001) tissues compared to controls. p16(+) and Nanog(+) cell density were higher in young (age <40 y/o) RA patients compared to the same group of age in non-inflammatory donors (p= 0.04 and p=0.02 respectively). Double p16 and hsp47 IF labelling confirmed that both hsp47(+) SF and hsp47(-) non-fibroblastic cell fractions contained p16(+) senescent cells. The percentage of SA-β-gal(+) in non-inflammatory control SF after 14 days in culture was positively correlated with age (p=0.008/r=0.75). This fraction was higher in RA (p=0.03) compared to healthy control SF, and increased upon SF exposure to H2O2 or TNFα (p=0.004 for both). Stress-induced senescence enhanced the senescence associated secretory phenotype (SASP) in SF, up-regulating the mRNA expression of pro-inflammatory factors such as IL-6, IL-8, MCP-1, and MMP-3. Consistently, senescent SF released more IL-6 and IL-8 than non-senescent SF. Finally, further stimulation with TNFα induced a higher increase in IL-6, IL-8 and MMP-3 mRNA expression in senescent SF compared to non-senescent SF.

Conclusion: Synovial tissues from patients with RA and OA shows an increased proportion of senescent SF. Stress-induced senescence in SF increases the production of pro-inflammatory mediators, and gives rise to an activation state that enhances the responsiveness to TNFα. Our data suggest that SF senescence is linked to the activation of a pro-inflammatory phenotype that may contribute to the pathogenesis of chronic arthritis.


Disclosure: M. J. Del Rey, None; A. Valin, None; A. Usategui, None; S. Ergueta, None; V. Miranda, None; J. Fernández-Felipe, None; J. D. Cañete, None; F. J. Blanco, None; G. Criado, None; J. L. Pablos, None.

To cite this abstract in AMA style:

Del Rey MJ, Valin A, Usategui A, Ergueta S, Miranda V, Fernández-Felipe J, Cañete JD, Blanco FJ, Criado G, Pablos JL. Fibroblasts Senescence Is Observed in Rheumatoid and Osteoarthritic Synovial Tissues and Triggers a Pro-Inflammatory Program Ex Vivo [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/fibroblasts-senescence-is-observed-in-rheumatoid-and-osteoarthritic-synovial-tissues-and-triggers-a-pro-inflammatory-program-ex-vivo/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibroblasts-senescence-is-observed-in-rheumatoid-and-osteoarthritic-synovial-tissues-and-triggers-a-pro-inflammatory-program-ex-vivo/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology